New hope for hard-to-treat neuroendocrine tumors? real-world study launches
NCT ID NCT07314164
First seen Jan 09, 2026 · Last updated May 15, 2026 · Updated 23 times
Summary
This study looks at how well the drug cabozantinib works and how safe it is for adults with neuroendocrine tumors (NETs) that have continued to grow despite at least one prior treatment. About 150 participants in Germany and Austria will be followed during their routine care. Doctors will track tumor response, side effects, and quality of life, but no extra tests are required beyond standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asklepios Kliniken Hamburg
NOT_YET_RECRUITINGHamburg, Germany
-
DRK Kliniken Berlin
NOT_YET_RECRUITINGBerlin, Germany
-
Evangelische Lungenklinik Berlin
RECRUITINGBerlin, Germany
-
Gemeinschaftspraxis Haematologie - Onkologie
RECRUITINGDresden, Germany
-
Johannes Wesling Klinikum Minden der Muehlenkreiskliniken AoeR
NOT_YET_RECRUITINGMinden, Germany
-
Kepler Universitaetsklinikum GmbH Linz
NOT_YET_RECRUITINGLinz, Austria
-
Klinikum Chemnitz
NOT_YET_RECRUITINGChemnitz, Germany
-
Krankenhaus Nordwest
NOT_YET_RECRUITINGFrankfurt, Germany
-
Krankenhaus St. Joseph-Stift Bremen GmbH
RECRUITINGBremen, Germany
-
MVZ Leipzig Mitte, MVZ Delitzsch
NOT_YET_RECRUITINGLeipzig, Germany
-
MVZ Muelheim an der Ruhr GmbH
NOT_YET_RECRUITINGMülheim, Germany
-
MVZ am Klinikum Aschaffenburg
NOT_YET_RECRUITINGAschaffenburg, Germany
-
MVZ fuer Haematologie und Onkologie Koeln am Sachsenring
NOT_YET_RECRUITINGCologne, Germany
-
Medizinische Studiengesellschaft Nord-West
RECRUITINGWesterstede, Germany
-
Medizinische Universitaet Graz
NOT_YET_RECRUITINGGraz, Austria
-
Philipps-Universitaet Marburg
NOT_YET_RECRUITINGMarburg, Germany
-
RKH Kliniken Ludwigsburg-Bietigheim gGmbH
RECRUITINGLudwigsburg, Germany
-
Studienzentrum UnterEms
NOT_YET_RECRUITINGLeer, Germany
-
Technische Univiersitaet (TU) Dresden
NOT_YET_RECRUITINGDresden, Germany
-
Uniklinikum Frankfurt
NOT_YET_RECRUITINGFrankfurt am Main, Germany
-
Universitaetsklinikum Essen
NOT_YET_RECRUITINGEssen, Germany
-
Universitaetsklinikum Giessen-Marburg
NOT_YET_RECRUITINGGiesen, Germany
-
Universitaetsklinikum Hamburg-Eppendorf
NOT_YET_RECRUITINGHamburg, Germany
-
Universitaetsklinikum Wuerzburg
RECRUITINGWürzburg, Germany
-
Universitaetsmedizin Goettingen
RECRUITINGGoettigen, Germany
-
Universiteatsmedizin Leipzig
NOT_YET_RECRUITINGLeipzig, Germany
-
Universitätsklinikum Tuebingen
RECRUITINGTübingen, Germany
-
pioh Studien und Mangement GbR
RECRUITINGCologne, Germany
Conditions
Explore the condition pages connected to this study.